Status:
COMPLETED
Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients
Lead Sponsor:
CRG UZ Brussel
Conditions:
Infertility
COVID
Eligibility:
FEMALE
Up to 45 years
Phase:
NA
Brief Summary
Recently, the world was shaken awake by a pandemic caused by a novel coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). In most nations drastic isolation measures were taken to ...
Eligibility Criteria
Inclusion
- Female
- Undergoing IVF/ICSI treatment
- Planned for an oocyte retrieval
- PCR positive of SARS-CoV-2 or high suspicion for COVID 19 based on CT scan
- Signed informed consent
Exclusion
- None
Key Trial Info
Start Date :
September 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04425317
Start Date
September 10 2020
End Date
January 1 2022
Last Update
February 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uz Brussels
Brussels, Belgium, 1090